Peptide inhibitors of flavivirus entry derived from the E protein stem

J Virol. 2010 Dec;84(24):12549-54. doi: 10.1128/JVI.01440-10. Epub 2010 Sep 29.

Abstract

Peptides derived from the "stem" of dengue virus (DV) type 2 (DV2) envelope (E) protein inhibit DV2 infectivity, targeting a late-stage fusion intermediate. We show here that stem peptides from all DV serotypes cross-inhibit DV1 to DV4 but that corresponding peptides derived from related flaviviruses do not. This failure to inhibit infection is not due to poor interaction with the E protein but rather to loss of association with the virion membrane. Residues 442 to 444 of the stem are determinants of inhibition; increasing hydrophobicity in this region increases inhibitory strength. These results support a two-step model of how stem-derived peptides inhibit viral entry.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aedes / drug effects
  • Aedes / virology*
  • Amino Acid Sequence
  • Animals
  • Cells, Cultured
  • Dengue / drug therapy*
  • Dengue / virology
  • Dengue Virus / chemistry
  • Dengue Virus / drug effects*
  • Hydrophobic and Hydrophilic Interactions
  • Molecular Sequence Data
  • Mutation / genetics
  • Peptide Fragments / chemistry
  • Peptide Fragments / pharmacology*
  • Serotyping
  • Viral Envelope Proteins / pharmacology*
  • Virion / drug effects
  • Virus Internalization / drug effects*

Substances

  • Peptide Fragments
  • Viral Envelope Proteins